A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
Authors
Keywords
-
Journal
Biotechnology Journal
Volume 10, Issue 11, Pages 1707-1718
Publisher
Wiley
Online
2015-07-16
DOI
10.1002/biot.201500131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension
- (2014) Magdalena Malm et al. Biotechnology Journal
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- (2014) J. Sorensen et al. JOURNAL OF NUCLEAR MEDICINE
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
- (2013) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
- (2013) Magdalena Malm et al. PLoS One
- Central amyloid- -specific single chain variable fragment ameliorates A aggregation and neurotoxicity
- (2013) R. M. Nisbet et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
- (2013) Jens Moreth et al. Frontiers in Aging Neuroscience
- Engineered antibody approaches for Alzheimer’s disease immunotherapy
- (2012) Remy Robert et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Staphylococcal display for combinatorial protein engineering of a head-to-tail affibody dimer binding the Alzheimer amyloid-β peptide
- (2012) Hanna Lindberg et al. Biotechnology Journal
- Surface display of a single-domain antibody library on Gram-positive bacteria
- (2012) Filippa Fleetwood et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Inhibition of Amyloid Formation
- (2012) Torleif Härd et al. JOURNAL OF MOLECULAR BIOLOGY
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
- (2012) N. Sehgal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bacterial display in combinatorial protein engineering
- (2011) John Löfblom Biotechnology Journal
- Mouse models of Alzheimer's disease
- (2011) Alicia M. Hall et al. BRAIN RESEARCH BULLETIN
- Non-immunoglobulin based protein scaffolds
- (2011) John Löfblom et al. CURRENT OPINION IN BIOTECHNOLOGY
- Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
- (2011) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid- Production in Vivo
- (2011) J. K. Atwal et al. Science Translational Medicine
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- (2010) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity
- (2010) Joel Lindgren et al. PROTEIN SCIENCE
- Sequestration of the Aβ Peptide Prevents Toxicity and Promotes Degradation In Vivo
- (2010) Leila M. Luheshi et al. PLOS BIOLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Interaction of Alzheimer’s Aβ Peptide with an Engineered Binding Protein—Thermodynamics and Kinetics of Coupled Folding–Binding
- (2008) Wolfgang Hoyer et al. JOURNAL OF MOLECULAR BIOLOGY
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
- Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
- (2008) Wolfgang Hoyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry
- (2008) N. Kronqvist et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Antibody-based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism, and analytical tools
- (2007) Peter Lichtlen et al. JOURNAL OF NEUROCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started